Selected Publications

“I publish as a means to educate.”

 

1.          Garfield SS, Poret AW, Evans RW. The cost-effectiveness of organ preservation methods in renal transplantation: US projections based on the Machine Preservation Trial. Transplantation Proceedings 41:3531-3536, 2009.

2.          Fine RN, Becker Y, DeGeest S, Eisen H, Ettenger R, Evans RW et al. Nonadherence consensus conference summary report. American Journal of Transplantation 9:35-41, 2009.

3.          Evans RW. Quality of life nonsense (letter to the editor). British Medical Journal, January 14, 2009 (Rapid Response). http://www.bmj.com/cgi/eletters/338/jan12_1/a3006.

4.          Evans RW. Financial, economic and insurance issues pertaining to intestinal transplantation: when is too much not enough? In: Langnas AN, Goulet O, Quigley EMM, Tappenden KA, (eds.) Intestinal Failure: Diagnosis, Management, and Transplantation. Malden, MA: Blackwell Publishing, 2008:363-377.

5.          Evans RW. Ethnocentrism is an unacceptable rationale for health care policy: a critique of transplant tourism position statements. American Journal of Transplantation 8:1089-1095, 2008.

6.          Ramakrishna G, Milavetz JJ, Zinsmeister AR, Farkouh ME, Evans RW, Allison TG, Smars PA, Gibbons RJ. The impact of exercise and imaging stress testing on the triage of patients with chest pain (CHEER Substudy). Mayo Clinic Proceedings 80:322-329, 2005.

7.          Evans RW. The cost-effectiveness of liver transplantation. Diseases of the Liver Updates 1(3):1-14, September 2005. (As a supplement to: Schiff E.R., Sorrell M.F., and Maddrey W.C., eds. Schiff’s Disease of the Liver, Ninth Edition. New York: Wolters Kluwer Health-Lippincott Williams & Wilkins, 2005.)

8.          Evans RW, Williams GE, Baron HM, Deng MC, Eisen HJ, Hunt SA, Khan MM, Kobashigawa JA, Marton EN, Mehra MR, Mital SR. The economic implications of noninvasive molecular testing for cardiac allograft rejection. American Journal of Transplantation 5:1553-1558, 2005.

9.          Leichtman AB, Ashby VB, Port FK, Merion RM, Evans RW, Wolfe RA. Disparate access to the liver transplant waitlist by age, gender, race, and geography. (Abstract) American Journal of Transplantation 4 (Supplement 8):518, 2004.

10.      Evans RW. Is quality of life a legitimate outcome? Transplant News 14(4): 4-5, 2004.

11.      Evans RW. Centers of excellence or discount centers? Transplant News 14(1): 4-5, 2004.

12.      Evans RW. Are transplant recipients insurable? Transplant News 14(2): 4-5, 2004.

13.      Shafer TJ, Schkade LL, Evans RW, O’Connor KJ, Reitsma W. Vital role of medical examiners and coroners in organ transplantation. American Journal of Transplantation 4: 160-168, 2003.

14.      Evans RW. Can transplant centers afford equity? Transplant News 13(23):4-5, 2003.

15.      Evans RW. Quality of care: a clinically significant, policy-relevant, and recurring issue in organ transplantation.  In:  Baumgartner W, Reitz B, Kasper E, Theodore J, (eds.), Heart and Lung Transplantation, 2nd Edition.  Philadelphia, PA: W. B. Saunders, Co., 2002:41-53.

16.      Evans RW. Kidney transplantation from donors without a heartbeat (letter to the editor). New England Journal of Medicine 347:1799-1800, 2002.

17.      Evans RW. The unkindest cut: where are all the transplant programs going? Graft 4:574-576, 2001.

18.      Evans RW. Costs and insurance coverage associated with permanent mechanical cardiac assist/replacement devices in the United States. Journal of Cardiac Surgery 16:280-296, 2001.

19.      Evans RW. Coming to terms with reality: why xenotransplantation is a necessity.  In:  Platt J, (ed.), Xenotransplantation, Washington, D.C: ASM Press, pp 29-51, 2001.

20.      Kim WR, Badley AD, Wiesner RH, Porayko MK, Seaberg EC, Keating MR, Evans RW, Dickson ER, Krom RAF, Paya CV. The economic impact of cytomegalovirus infection after liver transplantation. Transplantation 69:357-361, 2000.

21.      Evans RW. Economic impact of mechanical cardiac assistance. (Invited paper) Progress in Cardiovascular Diseases 43:81-94, 2000.

22.      Evans RW. Economic, actuarial, and contracting perspectives on liver transplantation. In: Maddrey WC, Schiff ER, Sorrell MF, (eds.), Liver Transplantation, 3rd Edition. Lippincott-Raven, 2000:479-489.

23.      Allison TG, Farkouh ME, Smars PA, Evans RW, Squires RW, Gabriel SE, Kopecky SL, Gibbon RJ, Reeder GS. for the Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. Management of coronary risk factors by registered nurses versus usual care in patients with unstable angina pectoris (a Chest Pain Evaluation in the Emergency Room [CHEER] substudy). American Journal of Cardiology 86:133-138, 2000.

24.      Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Malinchoc M, Benson JT, Crippin JS, Klintmalm GBG, Rakela J, Starzl TE, Krom RAF, Evans RW, Dickson ER. Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization, Hepatology 30(2):395-400, 1999.

25.      Gross CR, Malinchoc M, Kim WR, Evans RW, Wiesner RH, Petz JL, Crippin JS, Klintmalm GB, Levy MF, Ricci P, Therneau TM, Dickson ER. Quality of life before and after liver transplantation for cholestatic liver disease.  Hepatology 29(2):356-364, 1999.

26.      Evans RW. The folly of commercializing organ donation. In: Cecka CM, Terasaki PI, (eds.), Clinical Transplants 1998, Los Angeles: UCLA Tissue Typing Laboratory, pp. 342-343, 1999.

27.      Evans RW. How dangerous are financial incentives to obtain organs?  (Invited presentation paper), Transplantation Proceedings 31:1337-1341, 1999.

28.      Kim WR, Wiesner RH, Therneau TM, Poterucha JJ, Porayko MK, Evans RW, Klintmalm GB, Crippin JS, Krom RA, Dickson ER. Optimal timing of liver transplantation for primary biliary cirrhosis, Hepatology  28(1):33-38, 1998.

29.      Farkouh ME, Smars PA, Reeder GS, Zinsmeister AR, Evans, RW, Meloy TD, Kopecky SL, Allen M, Allison TG, Gibbons RJ, Gabriel SE. A clinical trial of a chest-pain observation unit for patients with unstable angina. The New England Journal of Medicine, 339:1882-1888, 1998.

30.      Evans RW. Cardiac replacement: Need, demand, and supply estimation.  In: Rose EA, Stevenson LW, (eds.)  Management of End-Stage Heart Disease, Boston, MA: Little, Brown and Company, pp 13-24, 1998.

31.      Evans RW, Kitzmann DJ. An economic analysis of kidney transplantation.  Surgical Clinics of North America, 78(1):149-174, 1998.

32.      Kim WR, Poterucha JJ, Hermans JE, Therneau TM, Dickson ER, Evans RW, Gross JB, Jr. Cost-effectiveness of 6 and 12 months of interferon therapy for chronic hepatitis C. Annals of Internal Medicine, 127:866-874, 1997.

33.      Evans RW, Kitzmann DJ. Contracting for services: liver transplantation in the era of mismanaged care. Clinics in Liver Disease 1(2):287-303, 1997.

34.      Evans RW, Kitzmann DJ. Current Opinions: How should livers be allocated in the United States? In: Cecka CM, Terasaki PI, (eds.), Clinical Transplants 1996, Los Angeles: UCLA Tissue Typing Laboratory, pp. 338-342, 1997.

35.      Kim WR, Therneau TM, Dickson ER, Evans RW. Preoperative predictors of resource utilization in liver transplantation. In: Terasaki PI, Cecka CM, (eds.), Clinical Transplants 1995, Los Angeles: UCLA Tissue Typing Laboratory, pp. 315-322, 1996.

36.      Evans RW. The effect of liver transplantation on local, regional and national health care. In: Busuttil, R.W., Klintmalm, G.B., (eds.) Transplantation of the Liver. Baltimore, Maryland: W. B. Saunders, Co., pp. 8 69-879, 1996.

37.      Evans RW.  Economic issues in transplantation: procedures and drugs.  In: Lieberman R, Mukherjee A, (eds.), Principles of Drug Development in Transplantation and Autoimmunity, New York, New York:  Raven Press, pp. 771-775, 1996. 

38.      Evans RW. When does the cost of living exceed the return on our investment?  The social and economic consequences of coronary bypass surgery in the elderly. In: Walter, P.J., (ed.) Coronary Bypass  Surgery in the Elderly, Dordrecht, The Netherlands: Kluwer Academic Publishers, pp. 121-134, 1995. 

39.      Evans RW. Socioeconomic aspects of heart transplantation. Current Opinion in Cardiology, 10:169-179; 1995. 

40.      Evans RW. Social, vocational, and financial consequences of liver transplantation. Liver Transplantation and Surgery, 1(5)Suppl 1:116-123, 1995.

41.      Evans RW. Organ transplantation in an era of economic constraint:  liver transplantation as a case study. Seminars in Anesthesiology, 14(2):127-135, 1995. 

42.      Evans RW. Liver transplantation in a managed care environment. Liver Transplantation and Surgery, 1(1):61-75, 1995.

43.      Evans RW, Manninen DL, Dong FB. Costs, insurance coverage, and reimbursement for heart transplantation. In: Shumway, S.J., Shumway, N.E., (eds.), Thoracic Transplantation. Cambridge, Massachusetts: Blackwell Scientific Publications, Inc., pp. 149-160, 1995.

44.      Evans RW. Quality of life in end-stage renal disease: practical issues in assessment. Dialysis Reports, 1(2):1-12, 1994.

45.      Evans RW. Organ transplantation and the inevitable debate as to what constitutes a basic health care benefit. In: Terasaki PI, Cecka M. (eds.), Clinical Transplants, 1993. Los Angeles, California: UCLA Tissue Typing Laboratory, pp. 359-391, 1994.

46.      Evans RW. Measuring the costs of heart transplantation. Primary Cardiology, 20(9):48-54, 1994.

47.      Evans RW. Case Two: Optimal approaches to heart failure and heart transplantation. Journal of Clinical Outcomes Management, 1(2):27-43, 1994.

48.      Orians CE, Evans RW, Ascher NL. Estimates of organ-specific donor availability for the U.S. Transplantation Proceedings 25(5):1541‑1542, 1993.

49.      O'Connell, JB, Gunnar RM, Evans RW, Fricker FJ, Hunt SA, Kirklin JK. Task Force 1:  Organization of heart transplantation in the U.S. Journal of the American College of Cardiology 22:1-64, 1993.

50.      Evans RW. Social, economic, and insurance issues in cardiac replacement.  In: O'Connell JB, Kaye MP, (eds.), Heart and Lung Transplantation 2000.  Austin, Texas: R. G. Landes Company, pp. 1-17, 1993.

51.      Evans RW. Organ procurement expenditures and the role of financial incentives. Journal of the American Medical Association 269(24):3113-3118, 1993.

52.      Evans RW. A cost-outcome analysis of retransplantation: The need for accountability. Transplantation Reviews 7(4):163-175, 1993.

53.      Evans RW, Manninen DL, Dong FB, McLynne DA. Is retransplantation cost-effective? Transplantation Proceedings 25(5):1694-1696, 1993.

54.      Evans RW, Manninen DL, Dong FB, Frist WH, Kirklin JW. The medical and surgical determinants of heart transplantation outcomes: the results of a consensus survey in the U.S. The Journal of Heart and Lung Transplantation 12(1 Part 1):42‑45, 1993.

55.      Evans RW, Manninen DL, Dong FB. An economic analysis of liver transplantation: costs, insurance coverage and reimbursement. Gastroenterology Clinics of North America 22(2):451-473, 1993.

56.      Evans RW, Manninen DL, Dong FB. An economic analysis of pancreas transplantation: costs, insurance coverage and reimbursement. Clinical Transplantation 7:166-174, 1993.

57.      Evans RW, Manninen DL, Dong FB. An economic analysis of heart-lung transplantation:  costs, insurance coverage and reimbursement. The Journal of Thoracic and Cardiovascular Surgery 105:972-978, 1993.

58.      Evans RW, Manninen DL, Dong FB, Ascher NL, Frist WH, Hansen JA, Kirklin JK, Perkins JD, Pirsch JD, Sanfilippo FP. Immunosuppressive therapy as a determinant of transplantation outcomes. Transplantation 55(6):1297, 1993.

59.      Evans RW, Manninen DL, Don, FB, Frist WH, Kirklin JK. Determinants of heart-lung transplantation outcomes:  results of a consensus survey. Annals of Thoracic Surgery 56(2):343-345, 1993.

60.      Manninen DL, Evans RW, Dugan MK.  Work disability, functional limitations, and the health status of kidney transplantation recipients posttransplant. In:  Terasaki, P.I., (ed.), Clinical Transplants, 1991. Los Angeles, California: UCLA Tissue Typing Laboratory, pp. 193-203, 1992. 

61.      Evans RW. Public and private insurer designation of transplantation programs. Transplantation 53(5):1041‑1046, 1992.

62.      Evans RW. Psychosocial aspects of heart transplantation: A comparative analysis. In:  Walter Paul J, (ed.), Quality of Life After Open Heart Surgery.  Dordrecht, The Netherlands: Kluwer Academic Publishers, pp. 469‑482, 1992.

63.      Evans RW. Need, demand, and supply in organ transplantation. Transplantation Proceedings 24(5):2152‑2154, 1992.

64.      Evans RW. Need, demand, and supply in kidney transplantation: a review of the data, an examination of the issues, and projections through the year 2000. Seminars in Nephrology 12(3):234-255, 1992.

65.      Evans RW, Orians CE, Ascher NL. The potential supply of organ donors: an assessment of the efficiency of organ procurement efforts in the United States. Journal of the American Medical Association 267:239-246, 1992.

66.      Evans RW, Dong FB, Manninen DL. The center effect in heart transplantation.  In: Terasaki, P.I., (ed.), Clinical Transplants, 1991. Los Angeles, California:  UCLA Tissue Typing Laboratory, pp. 45-59, 1992. 

67.      Manninen DL, Evans RW, Dugan MM, Rader B. The cost and outcomes of kidney transplant graft failure. Transplantation Proceedings 23:1312‑1314, 1991.

68.      Evans RW. Third party payment and the cost of transplantation. The Journal of the South Carolina Medical Association 87:345-352, 1991.

69.      Evans RW. Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: a comparative analysis. American Journal of Kidney Diseases 18(4)(Suppl 1):62-70, 1991.

70.      Evans RW, Manninen DL, Dong F. The center effect in kidney transplantation.  Transplantation Proceedings 23:1315-1317, 1991.

71.      Evans RW. The demand for transplantation in the United States. In:  Terasaki PI, (ed.), Clinical Transplants, 1990. Los Angeles, California: UCLA Tissue Typing Laboratory, pp. 319-327, 1990.

72.      Evans RW. The actual and potential supply of organ donors in the United States.  In: Terasaki PI, (ed.), Clinical Transplants, 1990. Los Angeles, California: UCLA Tissue Typing Laboratory, pp. 329-341, 1990.

73.      Evans RW. Quality of life assessment and the treatment of end-stage renal disease. Transplantation Reviews 4(1):28-51, July, 1990.

74.      Evans RW. Organ transplantation costs, insurance coverage, and reimbursement. In: Terasaki PI, (ed.), Clinical Transplants, 1990. Los Angeles, California: UCLA Tissue Typing Laboratory, pp. 343-355, 1990.

75.      Evans RW, Rader B, Manninen DL, Cooperative Multicenter EPO Clinical Trial Group. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Journal of the American Medical Association 263:825-830, 1990.

76.      Garrison LP, Jr., Evans RW. The economic impact of heart transplants on the Medicare program, 1985-1989.  In: Baumgartner WG, Reitz BA, (eds.), Heart and Heart-Lung and Transplantation. Baltimore, Maryland: Williams and Wilkens, pp. 41-50, 1989. 

77.      Evans RW. Money matters: Should ability to pay ever be a consideration in gaining access to transplantation? Transplantation Proceedings 21(3):3419-3423, 1989.

78.      Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW et al. Recombinant human erythropoietin in anemic patients with end-stage renal disease: results of a Phase III multicenter trial.  Annals of Internal Medicine 111(12):992-1000, 1989.

79.      Manninen DL, Evans RW. The costs and outcomes of kidney transplantation according to initial immunosuppressive drug protocol. In: Terasaki P, (ed.) Clinical Transplants, 1987. Los Angeles, California: UCLA Tissue Typing Laboratory, pp. 269-275, 1988.

80.      Manninen DL, Evans RW. A longitudinal assessment of the health status of diabetic and non-diabetic renal transplant recipients. In: Terasaki PI, (ed.) Clinical Transplants, 1988. Los Angeles, California: UCLA Tissue Typing Laboratory, pp. 203-209, 1988.

81.      Evans RW, Manninen DL. U.S. public opinion concerning the procurement and distribution of donor organs. Transplantation Proceedings 20(5):781-785, 1988.

82.      Evans RW, Manninen DL. Economic impact of cyclosporine in transplantation.  Transplantation Proceedings 20(3)(Suppl 3):49-62, 1988.

83.      Hart LG, Evans RW. The functional status of ESRD patients as measured by the Sickness Impact Profile. Journal of Chronic Diseases 40(Suppl 1):117S-130S, 1987.

84.      Evans RW. The economics of heart transplantation. Circulation 75:63‑87, 1987.

85.      Evans RW, Manninen DL, Maier AM. Selected characteristics of 444 heart donors. Transplantation Proceedings 19(1):2501‑2502, 1987.

86.      Ascher NL, Evans RW. Designation of liver transplant centers in the United States. Transplantation Proceedings 19(1):2405, 1987.

87.      Evans RW. The heart transplant dilemma. Issues in Science Technology 2(3):91‑101, 1986.

88.      Evans RW. Coverage and reimbursement for heart transplantation.  International Journal of Technology Assessment in Health Care 2:425‑449, 1986.

89.      Evans RW. Cost-effectiveness analysis of transplantation. Surgical Clinics of North America 66:603-616, 1986.

90.      Evans RW, Manninen DL, Garrison LP, Jr., Maier AM.  Donor availability as the primary determinant of the future of heart transplantation. Journal of the American Medical Association 255:1892‑1898, 1986.

91.      Evans RW, Maier TM. Outcome of patients referred for cardiac transplantation.  Journal of the American College of Cardiology 3(6):1312‑1317, 1986.

92.      Evans RW, Manninen DL, Garrison LP, Jr., Maier AM. Donor availability as the primary determinant of the future of heart transplantation. Journal of the American Medical Association (Southeast Asia) 2(11):17-23, 1986.

93.      Overcast TD, Merrikin KJ, Evans RW. Malpractice issues in heart transplantation.  American Journal of Law and Medicine 10:363‑395, 1985.

94.      Manninen DL, Evans RW. Public attitudes and behavior regarding organ donation. Journal of the American Medical Association 253:3111‑3115, 1985.

95.      Evans RW. The socioeconomics of organ transplantation. Transplantation Proceedings 17(Supplement 4):129‑136, 1985.

96.      Evans RW. The quality of life of patients with chronic renal disease: comparison of four treatment modalities. In: Kutner NG, Cardenas DD, Bower JD, (eds.) Rehabilitation and the Chronic Renal Disease Patient. New York, New York: S.P. Medical and Scientific Books, pp. 61‑83, 1985.

97.      Evans RW, Manninen DL, Hart LG, Maier A. The quality of life of kidney and heart transplant recipients. Transplantation Proceedings 17:1579‑1582, 1985.

98.      Evans RW, Manninen DL, Garrison LP, Jr., Hart LG, Blagg CR, Gutman RA, Hull AR, Lowrie EG. The quality of life of end‑stage renal disease patients.  New England Journal of Medicine 312:553‑559, 1985.

99.      Overcast TC, Evans RW, Bowen LE, Hoe MM, Livak CL. Problems in the identification of potential organ donors: misconceptions and fallacies associated with donor cards. Journal of the American Medical Association 251(12):1559‑1562, 1984.

100.   Evans RW, Manninen DL, Hart LG. A comparative assessment of the quality of life of successful kidney transplant patients according to source of graft.  Transplantation Proceedings 16:1353‑1358, 1984.

101.   Evans RW, Manninen DL, Gersh BJ, Hart LG, Rodin J. The need for and supply of donor hearts for transplantation. Heart Transplantation 4:57‑62, 1984.

102.   Evans RW. Health care technology and the inevitability of resource allocation and rationing decisions. Part I. Journal of the American Medical Association 249:2047‑2053, 1983.

103.   Evans RW. Health care technology and the inevitability of resource allocation and rationing decisions Part II. Journal of the American Medical Association 249:2208‑2219, 1983.

104.   Evans RW, Blagg CR, Bryan FA, Jr. Implications for health care policy: A social and demographic profile of hemodialysis patients in the United States.  Journal of the American Medical Association 245:487‑491, 1981.

 

 

 

 

 

Terms of Use | © 2010 United Network for the Recruitment of Transplantation Professionals. All rights reserved.| Privacy Policy